Mechanical embolus removal: A new day dawning

Stroke

Volumn 36, Issue 7, 2005, Pages 1439-1440

  Tomsick, Thomas A ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEREBROVASCULAR ACCIDENT; EMBOLECTOMY; MAGNETIC RESONANCE ANGIOGRAPHY; NOTE; PRIORITY JOURNAL; RECANALIZATION; REVASCULARIZATION;

EID: 22044452914     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/str.36.7.1439     Document Type: Note

References (11)

1. Furlan AJ, Fischer M. Devices, drugs, and the food and drug administration. Increasing implications for ischemic stroke. Stroke. 2005;36:398-399.
2. Becker KJ, Brott TG. Approval of the MERCI clot retriever. A critical review. Stroke. 2005;36:400-403.
3. Felten RP, Pena C, Provost MC, Schlosser MJ, Witten CM: The Food and Drug Administration medical device review process: clearance of a clot retriever for use in ischemic stroke. Stroke. 2005;36:404-406.
4. Neurological Device Panel Meeting, February 23, 2004. http://www.fda.gov/ ohrms/dockets/ac/04/transcripts/4022tl.htm. Accessed June 6, 2005.
5. Noser EA, Shaltoni HM, Hall CE, Alexandrov AV, Garami Z, Cacayorin ED, Song JK, Grotta JC, Campbell MS 3rd: Aggressive mechanical clot disruption: a safe adjunct to thrombolytic therapy in acute stroke? Stroke 2005;36:292-296.
6. Qureshi AI, Siddiqui AM, Suri MF, Kim SH, Ali Z. Yahia AM, Lopes DK, Boulos AS, Ringer AJ, Saad M, Guterman LR, Hopkins LN: Aggressive mechanical clot disruption and low-dose intra-arterial third-generation thrombolytic agent for ischemic stroke: a prospective study. Neurosurgery 2002;51:1319-1329.
7. Marder V, Chute D, Starkman S, Abolian A, Kidwell C, Ovbiagele B, Vinuela F, Duckwiler G, Jahan R, Rajajee V, Selco S, Saver JL: Histology of thrombi retrieved from acute ischemic stroke patients by endovascular embolectomy. Stroke. 2005;36:516. [Astract.]
8. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark WM, Silver F, Rivera F. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA. 1999;282:2003-2011.
9. Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, Dillon W, Warach S, Broderick J, Tilley B, Sacks D: Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology; Technology Assessment Committee of the Society of Interventional Radiology: Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke 2003;34:e109-e137.
10. IMS Study Investigators. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke (IMS) study. Stroke. 2004;35:904-912.
11. Yoneyama T, Nakano S, Kawano H, Iseda T, Ikeda T, Goya T, Wakisaka S: Combined direct percutaneous transluminal angioplasly and low-dose native tissue plasminogen activator therapy for acute embolic middle cerebral artery trunk occlusion. AJNR Am J Neuroradiol. 2002;23:277-281.